DSM Capital Partners’s Boston Scientific BSX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.4M	Buy	564,349 +559,625	+11,846%	+$44.8M	0.63%	26
2025 Q4	$450K	Buy	4,724 +747	+19%	+$73.2K	0.01%	36
2025 Q3	$388K	Buy	3,977 +1,119	+39%	+$116K	0.01%	37
2025 Q2	$307K	Buy	+2,858	New	+$289K	﹤0.01%	37
2024 Q4	–	Sell	-1,324	Closed	-$111K	–	52
2024 Q3	$111K	Hold	1,324	–	–	﹤0.01%	46
2024 Q2	$102K	Sell	1,324 -2,167,681	-100%	-$159M	﹤0.01%	45
2024 Q1	$149M	Sell	2,169,005 -669,618	-24%	-$43.1M	2.03%	18
2023 Q4	$164M	Buy	2,838,623 +444,794	+19%	+$23.7M	2.51%	14
2023 Q3	$126M	Sell	2,393,829 -96,116	-4%	-$5.04M	2.13%	19
2023 Q2	$135M	Sell	2,489,945 -1,162,600	-32%	-$60.7M	2.18%	17
2023 Q1	$183M	Sell	3,652,545 -1,347,768	-27%	-$63.5M	2.99%	14
2022 Q4	$231M	Sell	5,000,313 -590,902	-11%	-$25.6M	3.85%	10
2022 Q3	$217M	Buy	5,591,215 +294,050	+6%	+$11.8M	3.67%	9
2022 Q2	$197M	Buy	5,297,165 +268,026	+5%	+$10.9M	3.31%	8
2022 Q1	$223M	Buy	5,029,139 +1,174,491	+30%	+$50.9M	2.98%	9
2021 Q4	$164M	Sell	3,854,648 -271,157	-7%	-$11.4M	1.72%	19
2021 Q3	$179M	Buy	4,125,805 +501,060	+14%	+$22.2M	1.86%	16
2021 Q2	$155M	Buy	3,624,745 +465,847	+15%	+$19.6M	1.49%	24
2021 Q1	$122M	Buy	3,158,898 +167,679	+6%	+$6.35M	1.3%	24
2020 Q4	$108M	Buy	2,991,219 +480,339	+19%	+$17.3M	1.15%	24
2020 Q3	$95.9M	Buy	2,510,880 +447,561	+22%	+$17.2M	1.07%	22
2020 Q2	$72.4M	Sell	2,063,319 -1,554,378	-43%	-$56M	0.86%	26
2020 Q1	$118M	Buy	3,617,697 +1,335,632	+59%	+$52.2M	1.79%	17
2019 Q4	$103M	Buy	+2,282,065	New	+$95.5M	1.37%	25